RESUMO
STUDY QUESTION: Are arterial stiffness, carotid intima-media thickness and diastolic dysfunction increased in young women with polycystic ovary syndrome (PCOS) independently of the effects of obesity? SUMMARY ANSWER: Insulin resistance and central obesity are associated with subclinical cardiovascular dysfunction in young women, but a diagnosis of PCOS does not appear to confer additional risk at this age. WHAT IS KNOWN ALREADY: Some studies have shown that young women with PCOS may have increased measures of cardiovascular risk, including arterial stiffness, carotid intima-media thickness and myocardial dysfunction. However, it is difficult to establish how much of this risk is due to PCOS per se and how much is due to obesity and insulin resistance, which are common in PCOS and themselves associated with greater vascular risk. STUDY DESIGN, SIZE, DURATION: This cross-sectional study comprised 84 women with PCOS and 95 healthy volunteers, aged 16-45 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted in a university hospital. Subjects underwent a comprehensive assessment of body composition (including computed tomography (CT) assessment of visceral fat; VF), measurements of arterial stiffness (aortic pulse wave velocity; aPWV), common carotid intima-media thickness (ccIMT), diastolic function (longitudinal tissue velocity; e':a') and endocrinological measures. A sample size of 80 in each group gave 80% power for detecting a difference of 0.45 m/s in aPWV or a difference of 0.25 in e':a'. MAIN RESULTS AND THE ROLE OF CHANCE: After adjustment for age and body mass index (BMI), PCOS subjects had a greater insulin response (insulin area under the curve-IAUC) following glucose challenge (adjusted difference [AD] 35 900 pmol min/l, P < 0.001) and higher testosterone (AD 0.57 nmol/l, P < 0.001) and high molecular weight adiponectin than controls (AD 3.01 µg/ml, P = 0.02), but no significant differences in aPWV (AD -0.13 m/s, P = 0.33), ccIMT (AD -0.01 mm, P = 0.13), or e':a' (AD -0.01, P = 0.86) were observed. After adjustment for age, height and central pulse pressure, e':a' and aPWV were associated with logVF and IAUC. ccIMT was not related to logVF. The relationships between e':a' or aPWV and insulin resistance were only partly attenuated by adjusting for logVF. There was no significant relationship between aPWV or e':a' and either testosterone or adiponectin. LIMITATIONS, REASONS FOR CAUTION: The study recruited young women meeting the Rotterdam criteria for PCOS diagnosis; hence our findings may not be generalizable to older patients or those meeting other definitions of the syndrome. Biochemical hyperandrogenism was based solely on measurement of total testosterone. Cases and controls were not matched in advance for age and BMI, although the influence of these variables on the cardiovascular outcome measures was adjusted for. WIDER IMPLICATIONS OF THE FINDINGS: This study shows that central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS, whereas they are associated with both insulin resistance and central obesity. Obesity thus represents the greatest modifiable risk factor for cardiovascular disease in young women with PCOS and lifestyle measures which target weight reduction are critical. STUDY FUNDING/COMPETING INTERESTS: This study received no specific grant support from any funding body. The authors have no conflicts of interest to declare.
Assuntos
Doenças Cardiovasculares/complicações , Resistência à Insulina , Obesidade Abdominal/complicações , Síndrome do Ovário Policístico/complicações , Rigidez Vascular , Adolescente , Adulto , Composição Corporal , Feminino , Testes de Função Cardíaca , Humanos , Pessoa de Meia-Idade , Medição de RiscoRESUMO
OBJECTIVE: To assess circulating biochemical indices of endothelial function and nitro-oxidative stress in women with polycystic ovary syndrome (PCOS). DESIGN: Case-control study. POPULATION: Seventeen women with PCOS and eighteen age- and body mass index-matched healthy volunteers. METHODS: Nitric oxide (NO) metabolite levels were assessed by chemiluminescence. Electron paramagnetic resonance spectroscopy with spin trapping was used to assess oxidative stress ex vivo and in vitro. Antioxidant capacity was measured using oxygen radical absorbance. MAIN OUTCOME MEASURES: Biochemical indices of endothelial function, including NO metabolites, lipid-derived radicals and antioxidant capacity. RESULTS: Plasma NO metabolites were similar in the two groups (nitrite: 257±116 nmol/l [PCOS], 261±135 nmol/l [controls] P=0.93; nitrate: 27±7 µmol/l [PCOS], 26±6 µmol/l [controls] P=0.89). Alkoxyl free radicals (lipid-derived) were detected as the dominant species, but levels were not different between women with PCOS and controls whether measured directly ex vivo (median 7.2 [range 0.17-16.73]e6 arbitrary units [a.u.] and 7.2 [1.7-11.9]e6 a.u., respectively, P=0.57) or when stimulated in vitro to test radical generation capacity (1.23 [0.3-5.62]e7 a.u. and 1.1 [0.48-15.7]e7 a.u. respectively, P=0.71). In regression analysis, visceral fat area was independently associated with in vitro oxidative potential (ß=0.6, P=0.002). Total plasma antioxidant capacity (94±30% [PCOS], 79±24% [controls], P=0.09) and plasma hydroperoxides (7.5±4 µmol/l [PCOS], 6.7±5 µmol/l [controls], P=0.21) were not different between groups. However, lipophilic antioxidant capacity was lower in women with PCOS compared with controls (92±32 and 125±48%, respectively, P=0.02). CONCLUSIONS: Young overweight women with PCOS display a reduced lipophilic antioxidant capacity compared with healthy volunteers, but no change in circulating free radicals or nitro-oxidative stress.
Assuntos
Endotélio/metabolismo , Peróxidos Lipídicos/sangue , Óxido Nítrico/sangue , Obesidade/sangue , Estresse Oxidativo , Síndrome do Ovário Policístico/sangue , Espécies Reativas de Oxigênio/sangue , Adolescente , Adulto , Glicemia , Índice de Massa Corporal , Estudos de Casos e Controles , Espectroscopia de Ressonância de Spin Eletrônica , Feminino , Humanos , Resistência à Insulina , Gordura Intra-Abdominal , Medições Luminescentes , Pessoa de Meia-Idade , Obesidade/complicações , Sobrepeso/sangue , Sobrepeso/complicações , Síndrome do Ovário Policístico/complicações , Análise de Regressão , Gordura Subcutânea , Adulto JovemRESUMO
Ryo et al (2005 Diabetes Care 28 451-3) reported a new method for measuring the visceral fat area (VFA) by combining abdominal bioelectrical impedance analysis (BIA) with measurement of waist circumference (WC), but very few methodological details were provided. Furthermore, the study did not test the use of WC alone as an indicator of VFA even though others had previously reported a strong correlation. We sought to determine the optimal measurement technique and analysis for measuring VFA by abdominal BIA and WC. 18 volunteers (age 23-64 years) underwent measurement of WC, abdominal impedance (Bodystat 500 four-electrode system) and a single cross-sectional CT scan at the umbilicus. VFA derived using WC(3) and measurements of abdominal impedance from electrode pairs sited at the flank predicted the value of VFA measured by CT with correlation r = 0.904 (p < 0.0001); the optimizing power of WC was 3.3 (r = 0.905). However, the use of WC(1.9) alone, without involving BIA at all, provided a similar correlation (r = 0.923). Our small preliminary study shows that abdominal BIA is potentially a practicable non-invasive technique for measurement of VFA but casts doubt on whether it adds any value to the use of WC alone. Larger studies are now required to test this finding.